4D Molecular Therapeutics
FDMT
$25.34
Share price
-1.17%
Change (1 day)
39.38%
Change (1 year)
Categories
4D Molecular Therapeutics (FDMT) - Cash on Hand
Cash on Hand as of December 2023 : $0.28 B
According to 4D Molecular Therapeutics's latest financial reports the company has $0.28 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
4D Molecular Therapeutics - Cash on Hand chart (from 2018 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.28 B | 34.97% |
| 2022-12-31 | $0.21 B | -13.81% |
| 2021-12-31 | $0.24 B | -10.46% |
| 2020-12-31 | $0.27 B | 457.33% |
| 2019-12-31 | $49.65 M | -45.89% |
| 2018-12-31 | $91.76 M | 284.74% |
| 2017-12-31 | $23.85 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.20 B | -27.77% | 🇺🇸 USA |